In the context of B cell programs, both EP300 and HDAC1–3 are upregulated in HCC, with HDAC1/2 mediated immune infiltration—particularly involving B-cell responses—correlating with poor prognosis [105]. The gene discussed is HDAC1; the disease is hepatocellular carcinoma.